Rahsaan W. Thompson
Chief Legal Officer, Secretary and Compliance OfficeratZevra Therapeutics· In the 2025 proxy
Pay in FY2025Zevra Therapeutics stock +7.4% the same year
Rahsaan W. Thompson was paid $1.6M in FY2025 (Dec). Zevra Therapeutics stock rose 7.4% that year.
Pay$100 in the stock at the end of FY24 → $107
Experience
- Zevra TherapeuticsPublic company · 1 yr
- Chief Legal Officer, Secretary and Compliance Officer2025 – Present · 1 yrStock in role +20%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?